Mass Spectrometry in Metabolomics: What Lies Ahead
Yanhua Chen,Zeper Abliz
DOI: https://doi.org/10.4155/bio-2016-0258
IF: 2.695
2017-01-01
Bioanalysis
Abstract:BioanalysisVol. 9, No. 2 EditorialMass spectrometry in metabolomics: what lies aheadYanhua Chen & Zeper AblizYanhua Chen State Key Laboratory ofBioactive Substance and Function of Natural Medicines, Institute of MateriaMedica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, P. R. ChinaSearch for more papers by this author & Zeper Abliz*Author for correspondence: E-mail Address: zeper@imm.ac.cn State Key Laboratory ofBioactive Substance and Function of Natural Medicines, Institute of MateriaMedica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, P. R. China Centre for Bioimaging & Systems Biology, Minzu University of China, Beijing 100081, P. R. ChinaSearch for more papers by this authorPublished Online:14 Dec 2016https://doi.org/10.4155/bio-2016-0258AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: LC-MS/MSquantitative metabolomicsstandardizationReferences1 Nicholson JK, Lindon JC, Holmes E. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181–1189 (1999).Crossref, Medline, CAS, Google Scholar2 Wishart DS. Emerging applications of metabolomics in drug discovery and precision medicine. Nat. Rev. Drug Discov. 15(7), 473–484 (2016).Crossref, Medline, CAS, Google Scholar3 Beebe K, Kennedy AD. Sharpening precision medicine by a thorough interrogation of metabolic individuality. Comput. Struct. Biotechnol. J. 14, 97–105 (2016).Crossref, Medline, CAS, Google Scholar4 Cacciatore S, Loda M. Innovation in metabolomics to improve personalized healthcare. Ann. NY Acad. Sci. 1346, 57–62 (2015).Crossref, Medline, CAS, Google Scholar5 Yin PY, Peter A, Franken H et al. Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. Clin. Chem. 59, 833–845 (2013).Crossref, Medline, CAS, Google Scholar6 Yang W, Chen Y, Xi C et al. Liquid chromatography−tandem mass spectrometry-based plasma metabonomics delineate the effect of metabolites’ stability on reliability of potential biomarkers. Anal. Chem. 85, 2606–2610 (2013).Crossref, Medline, CAS, Google Scholar7 Gika H, Theodoridis G. Sample preparation prior to the LC-MS-based metabolomics/metabonomics of blood-derived samples. Bioanalysis 3(14), 1647–1661 (2011).Link, CAS, Google Scholar8 Chen Y, Xu J, Zhang R, Abliz Z. Methods used to increase the comprehensive coverage of urinary and plasma metabolomes by MS. Bioanalysis 8(9), 981–997 (2016).Link, CAS, Google Scholar9 Yuan M, Breitkopf SB, Yang X, Asara JM. A positive/negative ion–switching, targeted mass spectrometry–based metabolomics platform for bodily fluids, cells, and freshand fixed tissue. Nat. Protoc. 7(5), 872–881 (2012).Crossref, Medline, CAS, Google Scholar10 Chen S, Kong H, Lu X et al. Pseudotargeted metabolomics method and its application in serum biomarker discovery for hepatocellular carcinoma based on ultrahigh-performance liquid chromatography/triple quadrupole mass spectrometry. Anal. Chem. 85, 8326–8333 (2013).Crossref, Medline, CAS, Google Scholar11 Law KP, Lim YP. Recent advances in mass spectrometry: data independent analysis and hyper reaction monitoring. Expert Rev. Proteomics 10(6), 551–566 (2013).Crossref, Medline, CAS, Google Scholar12 Guo K, Li L. High-performance isotope labeling for profiling carboxylic acid-containing metabolites in biofluids by mass spectrometry. Anal. Chem. 82, 8789–8793 (2010).Crossref, Medline, CAS, Google Scholar13 Jiang R, Jiao Y, Xu F. Chemical derivatization-based LC-MS for metabolomics: advantages and challenges. Bioanalysis 8(18), 1881–1883 (2016).Link, CAS, Google Scholar14 Hooton K, Han W, Li L. Comprehensive and quantitative profiling of the human sweat submetabolome using high-performance chemical isotope labeling LC-MS. Anal. Chem. 88(14), 7378–7386 (2016).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByClinical Research in Cardiovascular Disease using MetabolomicsDevelopment of simultaneous targeted metabolite quantification and untargeted metabolomics strategy using dual-column liquid chromatography coupled with tandem mass spectrometryAnalytica Chimica Acta, Vol. 1037 Vol. 9, No. 2 Follow us on social media for the latest updates Metrics Downloaded 200 times History Published online 14 December 2016 Published in print January 2017 Information© Future Science LtdKeywordsLC-MS/MSquantitative metabolomicsstandardizationFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.Writing assistance was utilized in the production of this manuscript. The authors would like to thank Enago (www.enago.com) for the English language review.PDF download